Gene Therapy Treatment To Combat Parkinson's Disease
Links shared publicly online about this topic.
- 452total visits
Gene Therapy Treatment To Combat Parkinson's Disease
View full resource at medicalnewstoday.com
Tags: Neurology, Parkinson's Disease, Disease and Condition, Genes, Physician, disease, Medical
Most Recently Shared on March 9, 2011 at 10:05 am By:
Gene Therapy Treatment To Combat Parkinson's Disease http://mnt.to/3S3n #neurology
Also Shared By:
FDA grants orphan designation for AMT's hemophilia gene therapy program
news-medical.net — “Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its gene therapy program for the treatment of hemophilia B.” View full resource at news-medical.net
Most Recently Shared on January 4, 2012 at 3:35 pm By:
FDA grants orphan designation for AMT's hemophilia gene therapy program: Amsterdam Molecular Therapeutics, a lea... http://t.co/2rQWPl5w
EMA grants orphan designation to AMT for hemophilia B gene therapy
news-medical.net — “Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency (EMA) has granted orphan designation for its gene therapy program for the treatment of hemophilia B. Orphan designation in the European Union provides several benefits including 10 years of market exclusivity from product launch and access to the central authorization procedure.” View full resource at news-medical.net
Most Recently Shared on November 16, 2011 at 5:30 pm By:
Parkinson's Disease: EMA grants orphan designation to AMT for hemophilia B gene therapy: Amsterdam Molecular The... http://t.co/li0WP3Nm
Advances In Delivery Of Therapeutic Genes To Treat Brain Tumors And Other Neurological Disorders Highlighted In Human Gene Therapy
medicalnewstoday.com — “Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Fi” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2011 at 8:05 am By:
Advances In Delivery Of Therapeutic Genes To Treat Brain Tumors And Other Neurological Disorders Highlighted In Human ... http://mnt.to/3XPj
Neurologix Presents New Confirmatory Results For Phase 2 Study Of NLX-P101 In Parkinson's Disease To Recombinant DNA Advisory Committee
medicalnewstoday.com — “Neurologix, Inc. (OTCBB: NRGX) announced several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinso” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 7:05 am By:
MNT Clinical Trials Health News
Neurologix Presents New Confirmatory Results For Phase 2 Study Of NLX-P101 In Parkinson's Disease To Recombinant DNA A... http://mnt.to/3WXn
Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at INS 10th World Congress
news-medical.net — “Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.” View full resource at news-medical.net
Most Recently Shared on May 27, 2011 at 6:37 am By:
Parkinson's Disease: Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at INS 10th World Congres... http://bit.ly/jezasR
Parkinson's test breakthrough as single brain injection 'can ease symptoms' | Mail Online
dailymail.co.uk — “The treatment improved walking and dexterity by up to 61 per cent in patients. And just one jab may be enough to treat the disease for life, the Oxford-based researchers believe.” View full resource at dailymail.co.uk
Most Recently Shared on May 23, 2011 at 8:33 am By:
Preliminary results of a form of gene therapy for #parkinson's announced. http://bit.ly/mhb351
New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting
news-medical.net — “Oxford BioMedica plc, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin(R) for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.” View full resource at news-medical.net
Most Recently Shared on May 23, 2011 at 7:23 am By:
New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting: Oxford BioMedica plc, ... http://bit.ly/l62n8n
AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency
news-medical.net — “Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.” View full resource at news-medical.net
Most Recently Shared on May 20, 2011 at 11:57 am By:
Parkinson's Disease: AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficie... http://bit.ly/mHWzZo
Gene therapy holds promise for Parkinson's treatment
news-medical.net — “A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.” View full resource at news-medical.net
Most Recently Shared on March 17, 2011 at 11:41 am By:
Parkinson's Disease: Gene therapy holds promise for Parkinson's treatment: A first-of-its-kind study of gene the... http://bit.ly/gO9SYu
The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD
news-medical.net — “Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.” View full resource at news-medical.net
Most Recently Shared on March 17, 2011 at 9:54 am By:
The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD: Neurologix, Inc., announced... http://bit.ly/feUlaX
Gene therapy improves Parkinson's symptoms - Health - Health care - More health news - msnbc.com
msnbc.msn.com — “An experimental treatment improved symptoms of Parkinson's disease in a mid-stage test, echoing results of an earlier pilot study.” View full resource at msnbc.msn.com
Most Recently Shared on March 17, 2011 at 3:05 am By:
George Huba, Ph.D. Doctor, Psychologist, and PhD
Gene therapy improves Parkinson's symptoms, study shows http://on.msnbc.com/fyeyAB (via @news360app)
First Successful Double-Blind Study Of Gene Therapy For Parkinson's Disease - QualityPoint Technologies
qualitypointtech.net — “A randomised, double-blind gene therapy trial for Parkinson's disease has shown that injection of the glutamic acid decarboxylase (GAD) gene directly into the brain is safe and can significantly improve motor function in patients who are not responsive to drug treatment. These findings, published Online First in The Lancet Neurology, support the further development of this state-of-the-art treatment for Parkinson's disease and highlight the potential of gene therapy to alleviate the symptoms of ” View full resource at qualitypointtech.net
Most Recently Shared on March 17, 2011 at 1:35 am By:
First Successful Double-Blind Study Of Gene Therapy For Parkinson's Disease: A randomised, double-blind gene ther... http://bit.ly/e7UwH9
--Meaningful Improvements-- Using Gene Therapy in Parkinson--™s Disease
newswise.com — “A first-of-its-kind study of gene therapy in the treatment of Parkinson--™s disease determined that half of all patients who received the treatment had --clinically meaningful improvements-- of their symptoms within six months of surgery, says study lead author and co-principal investigator Peter LeWitt, M.D.” View full resource at newswise.com
Most Recently Shared on March 17, 2011 at 12:29 am By:
#health news: "Meaningful Improvements" Using Gene Therapy in Parkinson's Disease: A first-of-its-kind study of ... http://bit.ly/eQlUGM
Gene therapy improves Parkinson's symptoms - Health - Health care - More health news - msnbc.com
msnbc.msn.com — “An experimental treatment improved symptoms of Parkinson's disease in a mid-stage test, echoing results of an earlier pilot study.” View full resource at msnbc.msn.com
Most Recently Shared on March 17, 2011 at 12:15 am By:
msnbc.com - Health Health News
Gene therapy improves Parkinson's symptoms http://on.msnbc.com/gFWPYI
--Meaningful Improvements-- Using Gene Therapy in Parkinson--™s Disease
newswise.com — “A first-of-its-kind study of gene therapy in the treatment of Parkinson--™s disease determined that half of all patients who received the treatment had --clinically meaningful improvements-- of their symptoms within six months of surgery, says study lead author and co-principal investigator Peter LeWitt, M.D.” View full resource at newswise.com
Most Recently Shared on March 16, 2011 at 11:42 pm By:
newswise Health Communicator and Health News
"Meaningful Improvements" Using Gene Therapy in Parkinson's Disease: A first-of-its-kind study of gene therapy i... http://bit.ly/esNM6J
Advertisement
MNT Parkinson's News
@mnt_parkinsons
Neurologix Presents New Confirmatory Results For Phase 2 Study Of NLX-P101 In Parkinson's Disease To Recombinant DNA A... http://mnt.to/3WXn
1 year ago...